CHU de Quebec Research Centre

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evaluation of the Safety and Efficacy of Eneboparatide (AZP-3601) in Patients With Chronic Hypoparathyroidism	endocrine system disorder, hypoparathyroidism, parathyroid gland disorder	Active, not recruiting	Phase 3	2025-09-29		NCT05778071

Clinical trials